# Acadia Healthcare account plan

> Acadia Healthcare is a US behavioral healthcare provider with 280 facilities, about 12,800 beds, $3,312.8 million FY2025 revenue and about 25,000 employees.

## At a glance

Acadia Healthcare Company (NASDAQ: ACHC), headquartered in Franklin, Tennessee, runs acute psychiatric hospitals, addiction treatment facilities, outpatient opioid treatment centers and residential treatment centers across 40 states and Puerto Rico. Its stated strategy is to become the indispensable behavioral healthcare provider for high-acuity and complex-needs patients. FY2025 revenue was $3,312.8 million, up 5.0%, but a $996.2 million goodwill impairment led to a net loss attributable to Acadia of $1,102.8 million. Revenue is government-heavy: 57.7% Medicaid, 24.6% commercial and 14.3% Medicare in FY2025. At September 30, 2026 it operated 280 facilities with approximately 12,800 beds, and it has about 25,000 employees.

## Business units

- **Acute inpatient psychiatric facilities** (55% of FY2025 revenue): Hospitals that stabilise patients in crisis, with typical stays of three to five days for crisis stabilisation and five to twelve days for acute care; most new capacity, including joint ventures with health systems, is added here. Q3 2026 acute revenue was $525 million, up 11%, with volumes up 7.5%. The service line is the subject of a DOJ Criminal Division investigation.
- **Specialty treatment facilities** (17% of FY2025 revenue): Mainly residential recovery facilities for adults with addictive and co-occurring mental disorders, offering detoxification, inpatient, partial hospitalisation and outpatient care. Revenue fell 6.5% in Q1 2026 on closures and New York's exclusion of Medicaid referrals to Acadia's Pennsylvania facilities; Q3 2026 revenue was $136 million.
- **Comprehensive treatment centers (CTCs)** (17% of FY2025 revenue): Outpatient medication-assisted treatment for substance use disorders, mainly opioid addiction, with 178 CTCs at year-end 2025 and 15 opened during 2025. Q3 2026 revenue was $141 million, about 16% of revenue across 33 states; regional structures were consolidated to cut cost.
- **Residential treatment centers** (11% of FY2025 revenue): Non-hospital residential treatment for moderate to high acuity, largely for children and adolescents, with stays from three months to several years and accredited education programs. Q3 2026 revenue was $93 million, up 7%.

## Strategic priorities

- **Ramp new facilities to $200 million of EBITDA**: Management targets $200 million of incremental adjusted EBITDA relative to 2025 from facilities opened since 2023, with about $60 million expected in 2027 as startup losses fall from about $45 million to around $10 million.
- **Operational execution under the returning CEO**: Debra Osteen restructured acute operations into smaller divisions, created a new operating group for JV hospitals and recently opened facilities, removed a middle management layer and reduced corporate headcount.
- **Organic growth of existing facilities**: Acadia aims to broaden services, add beds and improve underperforming facilities; management sees patient day growth in a 3%-4% range going forward.
- **Revenue cycle and payer work**: With bad debts and denials worse than expected in early 2026, Acadia is improving documentation of patient acuity, appealing denials and rolling out technology and analytic tools, including early AI in revenue cycle management.
- **Capital discipline**: 2026 capex was cut to $210-230 million from $571.8 million in 2025, and the 2027 plan focuses on existing facilities and maintenance with no new facilities for now.

## Latest results

In Q3 2026 (quarter ended September 30, 2026) revenue was $895.3 million, up 5.1%, and same facility revenue grew 5.2%, with admissions up 6.6% and revenue per patient day up 4.0%. Net income attributable to Acadia was $34.5 million against $36.2 million a year earlier, and adjusted EBITDA was $176.4 million. Nine-month revenue was $2,590.0 million (+4.0%), and operating cash flow rose to $321.5 million while capex fell to $165.9 million. Guidance was raised for the third consecutive quarter: 2026 revenue of $3.44-3.46 billion, adjusted EBITDA of $615-625 million and adjusted EPS of $1.70-1.80.

## Investments and deals

- **New beds and joint ventures**: Acadia added 1,089 beds in 2025, including five JV facilities with Henry Ford Health, Geisinger Health, Ascension Seton, Fairview Health Services and ECU Health, and 542 beds in the first nine months of 2026, including JVs with Tufts Medicine, Orlando Health and Methodist Jennie Edmundson.
- **Coastal Pines de novo**: The 144-bed Coastal Pines Behavioral Health near Jacksonville is the fourth new acute facility opened in 2026 and the 16th since the beginning of 2023.
- **Capex reduction**: Capex was $571.8 million in 2025 ($467.4 million expansion, $104.4 million maintenance) and $165.9 million in the first nine months of 2026, against $478.6 million a year earlier.
- **Refinancing and buyback**: In 2025 Acadia signed a $1.0 billion revolving facility and a $650.0 million term loan maturing in 2030, issued $550.0 million of 7.375% Senior Notes due 2033 and authorised a $300.0 million share buyback, of which $250.0 million remains.

## Challenges and risks

- **Government investigations and litigation**: DOJ Criminal Division and SEC investigations into acute care admissions, length of stay and billing remain open; the 2019 Securities Litigation settled for $179.0 million and a 2025 securities class action survived a motion to dismiss.
- **Medicaid policy changes**: The One Big Beautiful Bill Act adds Medicaid work requirements in expansion states by December 31, 2026 and caps state directed payments, while enhanced ACA premium tax credits expired on December 31, 2025.
- **New York referrals to Pennsylvania**: New York's Medicaid change cut same facility revenue growth by about 1 point and volume growth by about 2.6 points; replacing those patients is still a work in progress, according to management.
- **Denials and bad debts**: Bad debts and payer denials worsened in Q1 2026 in a way management called more broad-based, and days sales outstanding rose to 52 from 49 at year-end 2025.
- **Liability and labor costs**: A $28.6 million unfavourable adjustment to professional and general liability reserves was booked in the first nine months of 2026, and management describes the labor market as very tight.

## What leadership says

> "our primary focus is operational execution and deriving more value from our facilities and recent bed additions." — Debra K. Osteen, Chief Executive Officer, Acadia Healthcare Q1 2026 Earnings Call, 2026-04-30

> "We remain confident in this group delivering on $200 million of adjusted EBITDA growth relative to 2025." — Debra K. Osteen, Chief Executive Officer, Acadia Healthcare Q1 2026 Earnings Call, 2026-04-30

> "documentation is the key to what we do" — Debra K. Osteen, Chief Executive Officer, Acadia Healthcare Q1 2026 Earnings Call, on revenue cycle, 2026-04-30

> "my goal when I returned as CEO was to position Acadia for long-term success." — Debra K. Osteen, Chief Executive Officer, Acadia Healthcare Q3 2026 Earnings Call, 2026-11-05


## Where a supplier can help

- **Revenue cycle and denial management**: Tied to the denials and bad debts challenge and the revenue cycle priority: clinical documentation, denial appeal and revenue cycle AI vendors fit a company already piloting AI there.
- **Ramping new facilities**: Tied to the $200 million EBITDA ramp priority: referral marketing, patient-intake and staffing partners can help new facilities fill beds and cut startup losses.
- **Compliance and investigation readiness**: Tied to the government investigations challenge: compliance, clinical audit and legal technology providers can support documentation of admissions, length of stay and billing.
- **Workforce recruiting and retention**: Tied to the liability and labor costs challenge: recruiting and workforce tools can support centralised hiring of facility CEOs and RNs in a very tight labor market.
- **Maintenance of an existing footprint**: Tied to the capital discipline priority: facility maintenance and building services suppliers fit a 2027 plan focused on existing facilities rather than new builds.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [Annual Report on Form 10-K for the fiscal year ended December 31, 2025](https://www.sec.gov/Archives/edgar/data/1520697/000119312526078266/achc-20251231.htm)

Annual report · 2026-02-27

- Acadia Healthcare is "the leading publicly traded pure-play provider of behavioral healthcare services in the U.S.": at December 31, 2025 it operated 277 behavioral healthcare facilities with over 12,500 beds in 40 states and Puerto Rico, with approximately 25,000 employees.
- FY2025 revenue was $3,312.8 million, up 5.0% from $3,154.0 million; same facility revenue grew 4.9% (patient days +2.1%, revenue per patient day +2.8%, admissions +2.3%).
- The year closed with a net loss attributable to Acadia of $1,102.8 million, driven by a $996.2 million non-cash goodwill impairment (higher professional and general liability expenses, lower Medicaid revenue projections tied to New York's exclusion of Medicaid referrals to its Pennsylvania facilities, and a sustained decline in the stock price).
- Revenue mix by service line: acute inpatient psychiatric facilities 55%, specialty treatment facilities 17%, comprehensive treatment centers (CTCs) 17%, residential treatment centers 11%.
- Payor mix is government-heavy: Medicaid 57.7%, commercial 24.6%, Medicare 14.3%, other 3.4%; no facility exceeded 4% and no state 14% of revenue.
- Growth strategy has five pathways (expansions of existing facilities, joint ventures, de novo facilities, acquisitions, continuum-of-care expansion); in 2025 it added 1,089 beds, opened five JV facilities (Henry Ford Health, Geisinger Health, Ascension Seton, Fairview Health Services, ECU Health) and 15 CTCs, and closed five facilities (382 beds).
- Capital expenditures were $571.8 million in 2025 ($467.4 million expansion, $104.4 million maintenance); maintenance capex is about 3% of revenue.
- Legal exposure is the dominant risk: an ongoing DOJ Criminal Division investigation of acute care admissions, length of stay and billing, SEC subpoenas also covering the CTC service line, $147.5 million of 2019 Securities Litigation settlement expense, and $135.3 million of government-investigation costs in 2025.
- Policy risks: the One Big Beautiful Bill Act tightens Medicaid eligibility and caps state directed payments, and enhanced ACA premium tax credits expired on December 31, 2025.

### [Quarterly Report on Form 10-Q for the quarter ended September 30, 2026](https://www.sec.gov/Archives/edgar/data/1520697/000119312526447412/achc-20260930.htm)

Interim report · 2026-11-04

- Q3 2026 revenue was $895.3 million, up 5.1%; revenue for the nine months ended September 30, 2026 was $2,590.0 million, up 4.0%.
- Same facility revenue grew 5.2% in Q3: revenue per patient day +4.0%, patient days +1.1%, admissions +6.6%, average length of stay -5.1%.
- Q3 net income attributable to Acadia was $34.5 million, against $36.2 million a year earlier; Q3 income before income taxes was $56.5 million.
- At September 30, 2026 Acadia operated 280 facilities with approximately 12,800 beds. Year to date it added 542 beds, including two wholly-owned facilities, three JVs (Tufts Medicine, Orlando Health, Methodist Jennie Edmundson) and three CTCs.
- Capital spending fell sharply: $165.9 million of capex in nine months, against $478.6 million a year earlier. Operating cash flow rose to $321.5 million, helped by insurance proceeds from the 2019 Securities Litigation and state supplemental payments.
- Consolidated total net leverage was 3.9x, with $710.1 million of revolver availability and $163.3 million of cash.
- Government investigation costs fell to $18.3 million in Q3 (from $38.7 million); the DOJ Criminal Division and SEC investigations remain open.
- Legal items: the 2019 Securities Litigation settled for $179.0 million, the Sandoval wrongful-death case settled for $15.0 million, and a 2025 securities class action survived a motion to dismiss.
- Severance for former CEO Christopher H. Hunter drove $3.9 million of management transition costs; Debra K. Osteen received a one-time CEO option award on January 20, 2026.

### [Acadia Healthcare (ACHC) Q3 2026 Earnings Call Transcript](https://www.fool.com/earnings/call-transcripts/2026/11/05/acadia-healthcare-achc-q3-2026-earnings-call-transcript/)

Executive talk · Debbie Osteen, Chief Executive Officer · 2026-11-05

- CEO Debbie Osteen said Q3 2026 revenue, adjusted EBITDA and adjusted EPS were above expectations, allowing guidance to be raised for the third consecutive quarter.
- Q3 revenue was $895 million (+5.1%), with same facility revenue +5.2%; acute revenue was $525 million (+11%), specialty $136 million, RTC $93 million (+7%) and CTC $141 million.
- Adjusted EBITDA was $176.4 million, including a $13.4 million accrual for the Florida supplemental payment program.
- 2026 guidance: revenue $3.44-3.46 billion, adjusted EBITDA $615-625 million, adjusted EPS $1.70-1.80, operating cash flow $375-400 million; capex cut to $210-230 million.
- Management expects about $60 million of incremental adjusted EBITDA in 2027 from the 16 new facilities opened since 2023, on the path to $200 million versus 2025; startup losses should fall from about $45 million to around $10 million.
- All planned new facilities are open, including the 144-bed Coastal Pines de novo near Jacksonville; 2027 capital will focus on existing facilities and maintenance rather than new de novos.
- New York's Medicaid change cut same facility revenue growth by about 1 point and volume growth by about 2.6 points; replacing those patients "is still a work in progress."
- Net leverage is about 3.9x; Florida and Ohio programs under review could add more than $20 million of EBITDA that is not in guidance.
- Most Medicaid patients are expected to be exempt from One Big Beautiful Bill work requirements; about 50% of Medicaid patients are in expansion states.

### [Acadia Healthcare (ACHC) Q1 2026 Earnings Call Transcript](https://www.fool.com/earnings/call-transcripts/2026/04/30/acadia-achc-q1-2026-earnings-call-transcript/)

Executive talk · Debra K. Osteen, Chief Executive Officer · 2026-04-30

- First earnings call after Debra Osteen returned as CEO, with CFO Todd Young on his last call before leaving for NVA.
- Q1 2026 revenue was $828.8 million (+7.6%), same facility revenue +7.3%, and acute revenue +14.2% on 6.2% higher inpatient volumes.
- Adjusted EBITDA was $144.2 million (+7.5%), $7.2 million above the top of guidance, helped by Ohio and Tennessee supplemental payments and corporate and facility cost efficiencies.
- 2026 guidance raised: adjusted EBITDA $580-615 million, adjusted EPS $1.35-1.60; revenue held at $3.37-3.45 billion; capex $255-280 million, more than $300 million below 2025.
- Osteen restructured acute operations: smaller divisions and a new operating group for JV hospitals and recently opened facilities under a newly hired leader. Middle management layers and corporate headcount were cut.
- The 2023-2025 facility cohort beat expectations, and management stays "confident" in $200 million of adjusted EBITDA growth relative to 2025.
- Bad debts and payer denials "continue to get a little bit worse"; Acadia is improving documentation, appealing denials and piloting AI in revenue cycle management.
- Specialty revenue fell 6.5% (closures and New York's decision on Pennsylvania facilities); acute inquiries were up over 20%; staff retention improved for the eighth consecutive quarter.

## Questions about Acadia Healthcare

### What does Acadia Healthcare do?

Acadia provides behavioral healthcare services in the US through acute psychiatric hospitals, addiction treatment facilities, outpatient opioid treatment centers and residential treatment centers.

### What is Acadia Healthcare's revenue?

FY2025 revenue was $3,312.8 million, up 5.0%. The company guides to 2026 revenue of $3.44-3.46 billion.

### How many employees does Acadia Healthcare have?

Acadia has approximately 25,000 employees, about 19,000 of them full-time.

### What is Acadia Healthcare's strategy?

Acadia is focused on operational execution: ramping the 16 facilities opened since 2023 toward $200 million of incremental adjusted EBITDA, growing existing facilities and cutting capex.

### Who leads Acadia Healthcare?

Debra K. Osteen returned as Chief Executive Officer in 2026, and David Duckworth is Interim CFO.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
